Colombo T, Lanfranchi M, Passini L, Quaini E, Russo C, Vitali E, Pellegrini A
A. De Gasperis Cardiac Surgery Division, Ente Ospedaliero Niguarda, Ca Granda, Milan, Italy.
Eur J Cardiothorac Surg. 1994;8(1):15-24. doi: 10.1016/1010-7940(94)90127-9.
From January 1982 to December 1991, 65 interventions were performed in 61 patients with active infective endocarditis (IE): 32 on native valves (Group 1) and 33 on prosthetic valves (Group 2). In Group 1, 23 patients had a known previous valve disease; major preoperative clinical complications occurred in 16 patients (50%); 84% were in NYHA classes III and IV. In Group 2 major preoperative clinical complications occurred in 13 patients (44.8%); 86% were in NYHA classes III and IV. The mean time interval between the onset of hemodynamic impairment of varying degrees and surgery was 13 +/- 15 days for Group 1, and 8 +/- 11 days for Group 2. In all cases, the native valves or prostheses were replaced by mechanical valve prostheses. Particular procedures were performed in three patients in Group 1 and five patients in Group 2. In Group 1 there were 8 hospital deaths (25%) and 11 (34.4%) non-fatal complications. In Group 2 there were 9 deaths (31%) and 14 (48.3%) non-fatal complications. Risk factors for hospital death were "preoperative low cardiac output syndrome" and "time interval between the onset of cardiac failure and surgery" in Group 1, "cardiac failure+sepsis" in Group 2, "time interval between the onset of cardiac failure and surgery" and "particular procedures" in all 61 patients. Sepsis alone and the type of pathogenic agent does not significantly affect the risk of death. The recurrence of acute IE was 12.6% in Group 1, and 20% in Group 2. The incidence of reintervention was 12.6% in Group 1 and 35% in Group 2.(ABSTRACT TRUNCATED AT 250 WORDS)
1982年1月至1991年12月,对61例活动性感染性心内膜炎(IE)患者实施了65次干预措施:32例针对自身瓣膜(第1组),33例针对人工瓣膜(第2组)。第1组中,23例患者既往有已知瓣膜疾病;16例患者(50%)出现主要术前临床并发症;84%为纽约心脏协会(NYHA)心功能Ⅲ级和Ⅳ级。第2组中,13例患者(44.8%)出现主要术前临床并发症;86%为NYHA心功能Ⅲ级和Ⅳ级。第1组中,不同程度血流动力学损害发作至手术的平均时间间隔为13±15天,第2组为8±11天。所有病例中,自身瓣膜或人工瓣膜均被机械瓣膜假体替代。第1组3例患者和第2组5例患者进行了特殊手术。第1组有8例医院死亡(25%)和11例(34.4%)非致命并发症。第2组有9例死亡(31%)和14例(48.3%)非致命并发症。第1组医院死亡的危险因素为“术前低心排血量综合征”和“心力衰竭发作至手术的时间间隔”,第2组为“心力衰竭+脓毒症”,所有61例患者的危险因素为“心力衰竭发作至手术的时间间隔”和“特殊手术”。单纯脓毒症和病原体类型对死亡风险无显著影响。第1组急性IE复发率为12.6%,第2组为20%。第1组再次干预发生率为12.6%,第2组为35%。(摘要截取自250字)